Share this article on:

Lipid Screening in HIV-Infected Veterans

Korthuis, P. Todd MD, MPH*; Asch, Steven M. MD, MPH†‡; Anaya, Henry D. PhD; Morgenstern, Hal PhD§; Goetz, Matthew Bidwell MD†‡; Yano, Elizabeth M. PhD, MSPH; Rubenstein, Lisa V. MD, MSPH; Lee, Martin L. PhD; Bozzette, Samuel A. MD, PhD

JAIDS Journal of Acquired Immune Deficiency Syndromes: March 1st, 2004 - Volume 35 - Issue 3 - p 253-260
Clinical Science

Background Lipid screening is recommended for patients taking protease inhibitors (PIs).

Methods We examined data from the Veterans Administration Immunology Case Registry to assess lipid screening among HIV-infected veterans who received PIs for at least 6 consecutive months during 1999 and 2001. We estimated crude and adjusted associations between lipid screening and patient characteristics (age, gender, HIV exposure, and race/ethnicity), comorbidities (AIDS, cardiovascular disease, diabetes, hypertension, smoking, and hyperlipidemia), and facility characteristics (urban location, case management, guidelines, and quality improvement programs).

Results Among 4065 patients on PIs, clinicians screened 2395 (59%) for lipids within 6 months of initiating treatment. Adjusting for patient characteristics, comorbidities, facility traits, and clustering, lipid screening was more common among patients who were cared for in urban areas (relative risk [RR] = 1.3, confidence limits: 1.0–1.5), diabetic (RR = 1.2, confidence limits: 1.1–1.3), or previously hyperlipidemic (RR = 1.4, confidence limits: 1.3–1.5) and less common among patients with a history of intravenous drug use (IVDU) (RR = 0.90, confidence limits: 0.79–1.0) or unknown HIV risk (RR = 0.85, confidence limits: 0.75–0.95).

Conclusions Six in 10 patients taking PIs receive lipid screening within 6 months of PI use. Systemic interventions to improve overall HIV quality of care should also address lipid screening, particularly among patients with unknown or IVDU HIV risk and those cared for in nonurban areas.

From *Oregon Health and Sciences University, Portland, OR; †Veterans Administration (VA) Greater Los Angeles Healthcare System and VA Health Services Research & Development (HSR&D) Center of Excellence for the Study of Healthcare Provider Behavior, Los Angeles, CA; ‡Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles School of Public Health, Los Angeles, CA and §Department of Epidemiology, School of Public Health, University of California at Los Angeles School of Public Health, Los Angeles, CA; and San Diego VA Medical Center and University of California at San Diego, San Diego, CA.

Received for publication June 19, 2003; accepted November 10, 2003.

Funded by the VA HSR&D Quality Enhancement Research Initiative (QUERI). P. Todd Korthuis was a VA Ambulatory Health Care Fellow (VA Office of Academic Affiliations) during the conduct of the project and received support for this project from VA HSR&D Center of Excellence for the Study of Healthcare Provider Behavior (HPF 94028), and Steven M. Asch is a recipient of the VA HSR&D Advanced Career Development Award.

Reprints: P. Todd Korthuis, Assistant Professor of Medicine, Oregon Health and Sciences University, 3181 SW Sam Jackson Park Road, Mail Code L-475, Portland, OR 97239–3098 (e-mail:

© 2004 Lippincott Williams & Wilkins, Inc.